Actis’s investment in Medis Group’s operations in Tunisia and Algeria

Lead party: Actis LLP (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Les Laboratoires MédiS (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria, Tunisia Transaction type: Investment, Exit · Asset class: Private Equity · Strategy: Secondary Sale · Instrument: Equity Lead investor/buyer: Actis LLP ·…


Lead party: Actis LLP (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Les Laboratoires MédiS (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria, Tunisia

Transaction type: Investment, Exit · Asset class: Private Equity · Strategy: Secondary Sale · Instrument: Equity

Lead investor/buyer: Actis LLP · Investors/buyers: Actis LLP · Sellers: AfricInvest Capital Partners LLC

Legal advisers: not identified in the source record.

Source: announced 2 September 2016. Original announcement: act.is.